Affiliation:
1. Clinical Infectious Diseases Hospital named after S.P. Botkin; Institute of Experimental Medicine
2. Clinical Infectious Diseases Hospital named after S.P. Botkin
3. Institute for Systems Theory
4. Institute of Experimental Medicine
5. Clinical Infectious Diseases Hospital named after S.P. Botkin; Saint-Petersburg State University
Abstract
Objective: to examine the state of the immunity to measles in different age groups.Materials and methods: In 2018, 4444 people were examined at the Diagnostic Center (virological). Among them, 3783 people were examined using the passive haemagglutination test for measles (manufactured by Pasteur Research Institute of Epidemiology and Microbiology, Russia). In the remaining 661 cases, the IgG to measles were detected using the enzyme-linked immunosorbent assay (ELISA) by VektoMeaseles IgG test (manufactured by Vector-Best, Russia). The correlation between the measles IgG level (ELISA) and the age was examined in 518 patients. Results: In this study, the immunity to measles was shown to be insufficient in all groups of observed people. Even among medical staff, nearly 10% had no protective level of measles antibodies. We have shown that the correlation between the measles IgG level and the age is statistically significant, so that the number of seronegative persons in different age groups differs significantly. Conclusion: The highest ratio of seronegative individuals was found in the age group between 18 and 25 years (52,33%), which can lead to serious measles outbreaks. Hence, this study confirms a strong need for additional immunization in all groups and especially in young population.
Reference7 articles.
1. Moss WJ. Measles. Lancet. 2017 2;390(10111):2490-2502
2. Melegaro A. Measles vaccination: no time to rest //The Lancet Global Health. – 2019. – 7(3). – P. e282-e283.
3. World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2016 global summary. URL: http:// apps.who. int/immunization_monitoring/globalsummary/cou ntries?countrycriteria%5Bcountry%5D%5B%5D=GIN&commit =OK (18.05.2018)
4. WHO. Measles in Europe: record number of both sick and immunized. Available from: http://www.euro.who.int/en/ media-centre/sections/press-releases/2019/measles-in-europerecord-number-of-both-sick-and-immunized [cited 2019 Feb 21]
5. Pozdnyakov A. A., Chernyavskaya O. P. Manifestations of the Epidemic Process of Measles and Rubella at the Present Stage. Epidemiology and Vaccinal Prevention. 2018; 17 (5): 45–53 (in Russian) DOI: 10.31631/2073-3046-2018-17-5-45-53
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Measles immunity in medical workers in Kazan;Epidemiology and Infectious Diseases;2022-07-29